NCT04853407View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)

PHASE3CompletedINTERVENTIONAL
Enrollment

558

Participants

Timeline

Start Date

December 5, 2018

Primary Completion Date

December 24, 2020

Study Completion Date

December 24, 2020

Conditions
Major Depressive Disorder (MDD)
Interventions
DRUG

LY03005 extended-release tablet

orally once a day

DRUG

Placebo

orally once a day

Trial Locations (1)

Unknown

The Sixth Hospital of Peking University, Beijing

All Listed Sponsors
lead

Luye Pharma Group Ltd.

INDUSTRY

NCT04853407 - A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD) | Biotech Hunter | Biotech Hunter